Nik Nik Abdul Rashid
Pediatric Hematology-Oncology · Las Vegas, NVNPI 1740290402
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,485 of the $31,840 with a category attached, or 70.6%. Global Blood Therapeutics, Inc. accounts for 60.8% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2021 at $15,456 and has fallen 99.9% since, to $20 in 2023.
Across 83 payments — averaging $383.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$19K
- Novartis$11K
- Genentech USA, Inc.$414
- Genentech, Inc.$342
- Incyte Corporation$199
- Novo Nordisk$195
- plus $801 from 14 others
Across 2 payments — averaging $1940.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Astrazeneca UK Limited$4K
What the payments were for
- Consulting fees$4,93515%
- Speaking & faculty fees$22,48571%
- Travel & lodging$1,4585%
- Food & beverage$2,8569%
- Education$1060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 22 | $19,365 |
| Novartis | 16 | $10,524 |
| Genentech USA, Inc. | 4 | $414 |
| Genentech, Inc. | 4 | $342 |
| Incyte Corporation | 2 | $199 |
| Novo Nordisk | 10 | $195 |
| Grifols Shared Services North America, Inc. | 2 | $144 |
| Grifols USA, LLC | 2 | $137 |
| Bayer | 3 | $133 |
| Emmaus Medical, Inc. | 4 | $86 |
| Spark Therapeutics, Inc. | 2 | $64 |
| Chiesi USA, Inc. | 2 | $43 |
| Octapharma USA, Inc. | 2 | $35 |
| Sanofi | 2 | $35 |
| Terumo BCT, Inc. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Aptevo Therapeutics Inc | 1 | $20 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Duchesnay USA Incorporated | 1 | $15 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Nevadato place this figure against a meaningful peer group, so we don't.
Other pediatric hematology-oncology in Las Vegas
- Daisy CortesLas Vegas$385K
- Jenny Gober McDanielLas Vegas$43K
- Aimee FoordLas Vegas$41K
- Joseph LaskyLas Vegas$16K
- Jerry ReevesLas Vegas$12K
- Waseem AlhushkiLas Vegas$3K
- Alan IkedaLas Vegas$1K
- Michael GrahamLas Vegas$1K
- Sumit GuptaLas Vegas$1K
- Raul Montiel-EsparzaLas Vegas$794
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.